Caffeine and cognitive function -
Also, while the test for the association between the genetic score and the outcome is a valid test for a causal relationship 40 , it cannot estimate the magnitude of the causal effect if it exists. In conclusion, we found no evidence that habitual coffee consumption is causally associated with global and memory cognition in mid- to later-life, despite the power to detect very small effects.
This suggests that interventions to protect cognition or slow cognitive decline using coffee are unlikely to be successful and should not be prioritized in future trials. That said, there was no evidence for any adverse effect, contrary to some previous observational studies, and hence it appears safe to consume coffee at least with respect to preserving memory function.
Fredholm, B. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological reviews 51 , 83— CAS PubMed Google Scholar. Santos, C. Caffeine intake and dementia: systematic review and meta-analysis.
Article PubMed Google Scholar. Ding, M. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation , — Article CAS PubMed Google Scholar.
Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes care 37 , — Article PubMed PubMed Central Google Scholar.
Ross, G. et al. Association of coffee and caffeine intake with the risk of Parkinson disease. Jama , — Freedman, N. Association of coffee drinking with total and cause-specific mortality. The New England journal of medicine , — Article CAS PubMed PubMed Central Google Scholar.
Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts. Loftfield, E. Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study.
American journal of epidemiology , — PubMed PubMed Central Google Scholar. Cornelis, M. Coffee, CYP1A2 genotype, and risk of myocardial infarction. Liu, Q. Nutrition Burbank, Los Angeles County, Calif.
Article Google Scholar. Wu, L. Coffee intake and the incident risk of cognitive disorders: A dose-response meta-analysis of nine prospective cohort studies.
Clinical nutrition Edinburgh, Scotland Kwok, M. Scientific reports 6 , Article CAS PubMed PubMed Central ADS Google Scholar. Feng, L. Cognitive function and tea consumption in community dwelling older Chinese in Singapore. Article CAS Google Scholar. Araujo, L.
Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study. Inconsistency of Association between Coffee Consumption and Cognitive Function in Adults and Elderly in a Cross-Sectional Study ELSA-Brasil.
Nutrients 7 , — Soroko, S. Reasons for changing caffeinated coffee consumption: the Rancho Bernardo Study. Journal of the American College of Nutrition 15 , 97— Davey, S.
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ , — Lawlor, D. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Article MathSciNet PubMed Google Scholar. Davey Smith, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies.
Human molecular genetics 23 , R89—98 Haller, S. Acute caffeine administration effect on brain activation patterns in mild cognitive impairment. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.
Molecular psychiatry 20 , — Genome-wide meta-analysis identifies regions on 7p21 AHR and 15q24 CYP1A2 as determinants of habitual caffeine consumption.
PLoS genetics 7 , e McMahon, G. Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption. PloS one 9 , e Article PubMed PubMed Central ADS Google Scholar.
Josse, A. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption. The American journal of clinical nutrition 96 , — Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.
Human molecular genetics 25 , — Llewellyn, D. Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement.
BMJ Clinical research ed. Bowden, J. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. International journal of epidemiology 44 , — Burgess, S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome.
International journal of epidemiology 43 , — Cole, S. Illustrating bias due to conditioning on a collider. International journal of epidemiology 39 , — Ye, Z. Association between circulating hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.
The lancet. Holmes, M. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. Nehlig, A. Is caffeine a cognitive enhancer? Levy, D. Genome-wide association study of blood pressure and hypertension.
Nature genetics 41 , — MacArthur, J. The new NHGRI-EBI Catalog of published genome-wide association studies GWAS Catalog. Nucleic acids research 45 , D—d Hamza, T.
Taylor, A. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. International journal of cancer , — Cowen, P. The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.
Journal of psychopharmacology Oxford, England 27 , — Guessous, I. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Human molecular genetics 21 , — Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank.
Addiction Abingdon, England Hernan, M. Epidemiology Cambridge, Mass. A review of instrumental variable estimators for Mendelian randomization.
Statistical methods in medical research Download references. This study was financially supported by J. Mason and H. Williams Memorial Foundation CT For full acknowledgement and study specific funding information, see the supplementary materials.
Australian Centre for Precision Health, University of South Australia, Adelaide, Australia. MRC Integrative Epidemiology Unit IEU at the University of Bristol, Bristol, UK. UK Centre for Tobacco and Alcohol Studies UKCTAS and School of Experimental Psychology, University of Bristol, Bristol, UK.
Center for Life Course Health Research, University of Oulu, Oulu, Finland. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. Helsinki Collegium for Advanced Studies, Helsinki, Finland.
Department of Psychology and Logopedics, Faculty of medicine, University of Helsinki, Helsinki, Finland. Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism. Uppsala University, Uppsala, Sweden.
Department of Surgical Sciences, Orthopaedics, Uppsala University, Uppsala, Sweden. Unit of Primary Health Care, Oulu University Hospital, Oulu, Finland. Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. Department of Pediatrics, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland. Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Oxford, OX3 7BN, UK.
Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden. Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK.
Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland. Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu, Oulu, Finland.
Department of Psychiatry, University Hospital of Oulu, Oulu, Finland. Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, , USA.
Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Stanford Cardiovascular Institute, Stanford University, CA, , USA. University of Exeter Medical School, Exeter, United Kingdom. South Australian Health and Medical Research Institute, Adelaide, Australia.
You can also search for this author in PubMed Google Scholar. Wrote the manuscript: A. Study supervision: K. Data analysis: A. Provision of administrative technical or material support: S. Data collection: S. Interpretation and manuscript revision: A. Correspondence to Elina Hyppönen.
receives grant from Pfizer unrelated to present project. is a scientific advisor for Precision Wellness, Cellink and Olink Proteomics for work unrelated to the present project. is supported by the UK National Institute for Health Research NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula PenCLAHRC.
The views expressed in this article are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health.
All other authors declare no competing interests. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.
Reprints and permissions. Zhou, A. Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to , participants.
Sci Rep 8 , Download citation. Received : 18 September Accepted : 24 April Published : 14 May Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Similar findings for the positive effect of chronic versus the negative effect of acute administration of caffeine on spatial memory and seizures in mice have also been demonstrated Therefore, although caffeine ingested as coffee is readily and essentially completely absorbed from the gastrointestinal tract and peak levels of caffeine in body fluids are reached about an hour after ingestion, long-term intake of caffeine may result in significant adaptive changes in the brain That lifetime coffee intake was more strongly associated with cognitive function than was current coffee intake in the present study may also suggest that it is the cumulative exposure to caffeine that is protective against losses in cognitive function.
The differences found between men and women may be due to unmeasured confounding or the somewhat smaller sample size of men, or they may be real. Unmeasured confounding may mask a true effect among men or create an illusory finding among women.
If the effect of chronic administration of caffeine on cognitive function is weak or if measurement of caffeine intake is poor, then the smaller sample size among men may result in nonsignificant findings.
A real finding may indicate that women are more vulnerable to the effects of chronic administration of caffeine than are men. The elimination half-life of caffeine ranges between 3 and 7 hours; however, among women, elimination is 20—30 percent shorter because of more rapid biotransformation 1.
Despite the differences in clearance, the levels of metabolites among men and women do not differ, however 1. Research by Carrillo and Benitez 43 indicates that, in healthy participants, women were more likely than men to experience acute toxic reactions, such as restlessness, palpitation, muscle tremor, and dizziness, after administration of high doses of caffeine compared with men.
Thus, gender differences may be due to pharmacodynamic differences in sensitivity to caffeine effects between men and women.
In another study, Relling et al. That coffee-cognition effects were found for women but not for men in the present study may also suggest that women are more susceptible to the cholinergic properties of caffeine than men are in older populations.
A meta-analysis indicated that women are at 1. Several limitations of the present study were considered. This study is an observational field study; therefore, conclusions about the causal effect of caffeine on cognitive function are limited. Self-reported lifetime coffee intake may be inaccurate, and the resulting nondifferential misclassification bias 1 would obscure a true association.
Because current coffee drinkers may have better cognitive function, they may have better recall on retrospective recalls, thus strengthening the results for current coffee intake. Lifetime assessment of coffee intake has unknown reliability and validity. However, self-reported habitual coffee intake has previously been shown to be reliable 47 , and dietary assessment data have been found to be accurate to within 10—15 percent after 10—15 years Although lifetime coffee intake was measured 1—4 years after cognitive testing, if caffeine has a cumulative effect, the hypothesized effect of caffeine on cognition would still be valid.
If caffeine intake is associated with mortality, survival bias could eliminate from the sample those with the highest levels of coffee consumption.
However, vital status did not differ by mean caffeine consumption based on the Willett Semiquantitative Food Frequency Questionnaire 20 after adjustment for age and cigarette smoking. Information bias may occur if those who responded to the mailed coffee survey differed from the total cohort.
The Rancho Bernardo cohort is relatively well educated; results of the present study of cognitive function may not generalize to less-educated populations. It was not possible to study the isolated effects of decaffeinated coffee, and no distinction between lifetime caffeinated coffee intake and overall caffeine consumption was made.
However, Stavric 49 reports that the physiologic effects of caffeine are very closely associated with drinking coffee. The results of this study suggest that coffee intake may be positively associated with cognitive performance among elderly women.
The results of the present study should not, however, be used to promote increased coffee consumption, as some research indicates that coffee intake may be associated with increased risk of cardiovascular disease and other chronic diseases Long-term studies using population-based samples are needed to further elucidate the effects of caffeine on cognitive performance among the elderly.
The authors gratefully acknowledge the contribution made by Dr. Deborah L. Wingard for her comments on the analysis and interpretation of this study. Correspondence to Dr. Elizabeth Barrett-Connor, University of California, San Diego, Gilman Drive, Department , La Jolla, CA email: ebarrettconnor ucsd.
FIGURE 1. Regular current drinkers of coffee are defined as those drinking 1 or more cups per month. Age-adjusted distribution of covariates by quintile of lifetime and current caffeinated coffee intake by gender, Rancho Bernardo, California, — James JE. London, England: Academic Press, Barrone JJ, Roberts H.
Human consumption of caffeine. In: Dews PB, ed. Berlin, Germany: Springer-Verlag, — Lienert GA, Huber H. Differential effects of coffee on speed and power tests. J Psychol ; 63 : — Bättig K, Buzzi R, Martin JR, et al. The effects of caffeine on physiological functions and mental performance. Experientia ; 40 : — Bättig K, Buzzi R.
Effect of coffee on the speed of subject-paced rapid information processing. Neuropsychobiology ; 16 : — Lieberman HR, Wurtman RJ, Emde GG, et al. The effects of low doses of caffeine on human performance and mood.
Psychopharmacology Berl ; 92 : — Loke WH. Effects of caffeine on mood and memory. Physiol Behav ; 44 : — Smith AP, Rusted JM, Eaton-Williams P, et al.
Effects of caffeine given before or after lunch on sustained attention. Neuropsychobiology ; 23 : —3. Frewer LJ, Lader MH. The effects of caffeine on two computerised tests of attention and vigilance. Hum Psychopharmacol ; 6 : — Smith AP, Brockman P, Flynn R, et al.
Investigation of the effects of coffee on alertness and performance during the day and night. Neuropsychobiology ; 27 : — Smith AP, Maben A, Brockman P.
Effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharmacol ; 27 : —6.
Lorist MM, Snel J, Kok A. Influence of caffeine on information processing stages in well rested and fatigued subjects.
Psychopharmacology Berl ; : — Reidel W, Hogervorst R, Leboux F, et al. Caffeine attenuates scopolamine-induced memory impairments in humans. Durlach PJ. The effects of a low dose of caffeine on cognitive performance. Hindmarch I, Quinlan PT, Moore KL, et al. The effects of black tea and other beverages on aspects of cognition and psychomotor performance.
Psychopharmacology Berl ; : —8. Jung RE, Yeo RA, Gangestad SW. Developmental instability predicts individual variation in verbal memory skill after caffeine ingestion. Neuropsychiatry Neuropsychol Behav Neurol ; 13 : —8. Jarvis MJ.
Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology Berl ; : 45 — Reidel WJ, Jolles J.
Cognition enhancers in age-related cognitive decline. Drugs Aging ; 8 : — Powell DH, Whitla DK. Normal cognitive aging: toward empirical perspectives. Curr Dir Psychol Sci ; 3 : 27 — Willett WC, Sampson L, Stampfer MJ, et al.
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol ; : 51 — Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in cerebral gray matter of elderly subjects.
Br J Psychiatry ; : — Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. New York, NY: Oxford University Press, Buschke H, Fuld PA.
Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology ; 24 : — Russell EW. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol ; 43 : —9. Wechsler D. A standardized memory scale for clinical use.
J Psychol ; 19 : 87 — Folstein MF, Folstein SE, McHugh PR. J Psychiatr Res ; 12 : — Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc ; 40 : — Reitan R.
Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Mot Skills ; 8 : —6. Borkowski JB, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia ; 5 : — Dodrill CB. Myths of neuropsychology: further considerations.
Clin Neuropsychol ; 13 : — Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry ; 4 : — Swift CG, Tiplady B. The effects of age on the response to caffeine.
Psychopharmacology Berl ; 94 : 29 — Rees K, Allen D, Lader M. The influences of age and caffeine on psychomotor and cognitive function. Shadlen MF, Larson EB. Postgrad Med ; : — Molchan SE, Martinez RA, Hill JL, et al. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model.
Brain Res Brain Res Rev ; 17 : — Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol ; 76 : 93 — Kopf SR, Melani A, Pedata F, et al. Adenosine and memory storage: effect of A 1 and A 2 receptor antagonists.
Rudolphi KA, Keil M, Fastbom J, et al. Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine A 1 receptors by caffeine treatment. Neurosci Lett ; : — Schingnitz G, Kufner-Muhl U, Ensinger H, et al.
Selective A 1 -antagonists for treatment of cognitive deficits. Nucleosides Nucleotides ; 5 Von Lubitz DKJE, Paul IA, Bartus RT, et al. Effects of chronic administration of adenosine A 1 receptor agonist and antagonist on spatial learning and memory. Eur J Pharmacol ; : — Ross GW, Abbott RD, Petrovitch H, et al.
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA ; : —9. Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [ 18 F]fluorodopa positron emission tomographic study. Arch Neurol ; 57 : —5. Carrillo JA, Benitez J.
CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. Br J Clin Pharmacol ; 41 : —8. Relling MV, Lin JS, Ayers GD, et al. Clin Pharmacol Ther ; 52 : — Gao S, Hendrie HC, Hall KS, et al.
The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry ; 55 : — Farrer LA, Cupples LA, Haines JL, et al.
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA ; : — James JE, Bruce MS, Lader MH, et al.
Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol ; 27 : — Sobell J, Block G, Koslowe P, et al. Validation of a retrospective questionnaire assessing diet 10—15 years ago. Am J Epidemiol ; : — Stavric B. Food Chem Toxicol ; 30 : — Oxford University Press is a department of the University of Oxford.
It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Navbar Search Filter American Journal of Epidemiology This issue Public Health and Epidemiology Books Journals Oxford Academic Mobile Enter search term Search.
Issues More Content Advance articles Editor's Choice years of the AJE Collections Submit Author Guidelines Submission Site Open Access Options Purchase Alerts About About American Journal of Epidemiology About the Johns Hopkins Bloomberg School of Public Health Journals Career Network Editorial Board Advertising and Corporate Services Self-Archiving Policy Dispatch Dates Journals on Oxford Academic Books on Oxford Academic.
Issues More Content Advance articles Editor's Choice years of the AJE Collections Submit Author Guidelines Submission Site Open Access Options Purchase Alerts About About American Journal of Epidemiology About the Johns Hopkins Bloomberg School of Public Health Journals Career Network Editorial Board Advertising and Corporate Services Self-Archiving Policy Dispatch Dates Close Navbar Search Filter American Journal of Epidemiology This issue Public Health and Epidemiology Books Journals Oxford Academic Enter search term Search.
Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract.
MATERIALS AND METHODS. Journal Article. Coffee Consumption and Cognitive Function among Older Adults. Marilyn Johnson-Kozlow , Marilyn Johnson-Kozlow. From the Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA.
Oxford Academic. Google Scholar. Donna Kritz-Silverstein. Elizabeth Barrett-Connor. Deborah Morton. PDF Split View Views. Select Format Select format.
ris Mendeley, Papers, Zotero. enw EndNote. bibtex BibTex. txt Medlars, RefWorks Download citation.
Caffeine, which is widely used cgonitive enhancing athletic funtion, has been suggested to have Caffeine and cognitive function positive impact on cognition via stimulating the brain. However, Cafeine Caffeine and cognitive function published to Functioj has explored snd effects swimming and calorie burn different doses Caffeine and cognitive function caffeine ingestion on brain activation via cortical hemodynamics. The purpose of the present crossover, double-blind study was to investigate the effects of low, moderate, and high doses of caffeine ingestion on cognitive performance and brain activation. The effects of each treatment condition were evaluated by Stroop tasks before and 60 min after the ingestion of caffeine. Reaction time RT and accuracy of responses to congruent and incongruent stimuli were assessed. As an index of brain activation with cognition, levels of oxygenated hemoglobin HbO were measured via near-infrared spectroscopy. Late in my PhD, Body recomposition diet did functiin a cognitibe unhealthy clgnitive to energy drinks, but I managed to knock that on the head once Caffeine and cognitive function Belly fat reduction routines submitted. People start their Cgonitive with Caffeone, they turn to coffee when they need to concentrate, fuunction they rely on coffee to get them through periods of hard or late work. Caffeine is the most frequently consumed psychostimulant and second most popular beverage after water. Consistent with this, the evidence does suggest you can build up a tolerance to caffeine, particularly in the central nervous system i. the mental effects. Whilst taste might be the central motivator for some drinkers, I suspect it is the psychological and physical effects of caffeine that keep most people drinking it on a regular basis.
0 thoughts on “Caffeine and cognitive function”